RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
OncoSec Medical Stock

OncoSec Medical ROA 2024

OncoSec Medical ROA

-1.56

Ticker

ONCS

ISIN

US68234L3069

WKN

A2PKW3

In 2024, OncoSec Medical's return on assets (ROA) was -1.56, a 94.65% increase from the -0.8 ROA in the previous year.

OncoSec Medical Aktienanalyse

What does OncoSec Medical do?

OncoSec Medical Inc is a US-based company specializing in the development of cancer treatment methods through immunotherapy. The company was founded in 2011 and is headquartered in San Diego, California. The history of OncoSec Medical Inc began with the idea of improving tumor treatments through electroporation. Electroporation is a process that uses electric pulses to increase the permeability of cell membranes. This facilitates the exchange of molecules and the uptake of drugs, which is used in the treatment of cancer cells. The business model of OncoSec Medical Inc is based on the development and commercialization of immunotherapies to combat cancer. Electroporation is used to locally infect tumor lesions with reactivated T-cells and other immune cells to generate an immune response. OncoSec Medical Inc has developed a proprietary platform called ImmunoPulse, which combines electroporation and immunotherapy. The company is divided into various divisions, including research and development, clinical trials, manufacturing, and distribution. Research and development focus on identifying potential immunotherapies and testing drug candidates. Clinical trials are designed to confirm the effectiveness and safety of therapies through clinical testing. Manufacturing involves the production of drug candidates and clinical preparations in accordance with Good Manufacturing Practices (GMPs). Distribution includes the sale and marketing of approved therapies to patients and healthcare providers. OncoSec Medical Inc offers a variety of immunotherapies for the treatment of various types of cancer. This includes ImmunoPulse IL-12 therapy, which is used to treat metastatic melanoma. The company is also working on several other therapies, including the Verapamil-Plus-IL-2 protocol for the treatment of breast and prostate cancer. In summary, OncoSec Medical Inc is an emerging biotechnology company specializing in the development and commercialization of immunotherapies to combat cancer. Through its proprietary ImmunoPulse platform and extensive research and development, the company strives to provide effective and safe treatment options for cancer patients, fully harnessing the potential of immunotherapy. OncoSec Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding OncoSec Medical's Return on Assets (ROA)

OncoSec Medical's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing OncoSec Medical's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider OncoSec Medical's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in OncoSec Medical’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about OncoSec Medical stock

What is the Return on Assets (ROA) of OncoSec Medical this year?

The Return on Assets (ROA) of OncoSec Medical is -1.56 undefined this year.

What was the ROA of OncoSec Medical compared to the previous year?

The ROA of OncoSec Medical has increased by 94.65% compared to the previous year.

What consequences do high ROA have for investors of OncoSec Medical?

A high ROA is advantageous for investors of OncoSec Medical, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in OncoSec Medical?

A low ROA can be unfavorable for investors of OncoSec Medical as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of OncoSec Medical affect the company?

An increase in ROA of OncoSec Medical can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of OncoSec Medical impact the company?

A reduction in the ROA of OncoSec Medical can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of OncoSec Medical?

Some factors that can influence the ROA of OncoSec Medical include revenue, operating costs, asset structure, and industry average.

Why is the ROA of OncoSec Medical important for investors?

The ROA of OncoSec Medical is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can OncoSec Medical take to improve ROA?

To improve ROA, OncoSec Medical can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does OncoSec Medical pay?

Over the past 12 months, OncoSec Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OncoSec Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of OncoSec Medical?

The current dividend yield of OncoSec Medical is .

When does OncoSec Medical pay dividends?

OncoSec Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of OncoSec Medical?

OncoSec Medical paid dividends every year for the past 0 years.

What is the dividend of OncoSec Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is OncoSec Medical located?

OncoSec Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von OncoSec Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of OncoSec Medical from 10/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/21/2024.

When did OncoSec Medical pay the last dividend?

The last dividend was paid out on 10/21/2024.

What was the dividend of OncoSec Medical in the year 2023?

In the year 2023, OncoSec Medical distributed 0 USD as dividends.

In which currency does OncoSec Medical pay out the dividend?

The dividends of OncoSec Medical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The OncoSec Medical stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von OncoSec Medical

Our stock analysis for OncoSec Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OncoSec Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.